PT1331927E - Composição tópica contendo pelo menos uma vitamina d ou um análogo de vitamina d e, pelo menos, um corticosteróide - Google Patents

Composição tópica contendo pelo menos uma vitamina d ou um análogo de vitamina d e, pelo menos, um corticosteróide Download PDF

Info

Publication number
PT1331927E
PT1331927E PT01971719T PT01971719T PT1331927E PT 1331927 E PT1331927 E PT 1331927E PT 01971719 T PT01971719 T PT 01971719T PT 01971719 T PT01971719 T PT 01971719T PT 1331927 E PT1331927 E PT 1331927E
Authority
PT
Portugal
Prior art keywords
vitamin
corticosteroid
analogue
composition containing
topical composition
Prior art date
Application number
PT01971719T
Other languages
English (en)
Inventor
Erik Johannes Didriksen
H Y Gert
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1331927(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of PT1331927E publication Critical patent/PT1331927E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
PT01971719T 2000-10-27 2001-09-26 Composição tópica contendo pelo menos uma vitamina d ou um análogo de vitamina d e, pelo menos, um corticosteróide PT1331927E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24347100P 2000-10-27 2000-10-27

Publications (1)

Publication Number Publication Date
PT1331927E true PT1331927E (pt) 2008-01-30

Family

ID=22918889

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01971719T PT1331927E (pt) 2000-10-27 2001-09-26 Composição tópica contendo pelo menos uma vitamina d ou um análogo de vitamina d e, pelo menos, um corticosteróide

Country Status (22)

Country Link
US (1) US6787529B2 (pt)
EP (1) EP1331927B1 (pt)
JP (3) JP4451061B2 (pt)
KR (1) KR100844285B1 (pt)
CN (1) CN100382803C (pt)
AT (1) ATE380542T1 (pt)
AU (2) AU2001291637B2 (pt)
BR (1) BRPI0114927B8 (pt)
CA (1) CA2423930C (pt)
CY (1) CY1107294T1 (pt)
CZ (1) CZ305984B6 (pt)
DE (1) DE60131881T2 (pt)
DK (1) DK1331927T3 (pt)
ES (1) ES2298264T3 (pt)
HK (1) HK1077208A1 (pt)
HU (1) HU230005B1 (pt)
IL (2) IL154888A0 (pt)
MX (1) MXPA03003511A (pt)
PL (1) PL212660B1 (pt)
PT (1) PT1331927E (pt)
RU (1) RU2271810C2 (pt)
WO (1) WO2002034235A1 (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
MXPA03003511A (es) * 2000-10-27 2004-05-04 Leo Pharma As Composicion topica que contiene al menos una vitamina d o un analogo de vitamina de y al menos un corticosteroide.
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
JP2006511545A (ja) * 2002-12-17 2006-04-06 ガルデルマ・ソシエテ・アノニム カルシトリオール及びプロピオン酸クロベタゾールの組み合わせ物を含む医薬組成物
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871693B1 (fr) * 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
AU2005267629A1 (en) * 2004-07-28 2006-02-02 Lipopeptide Ab New use
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
JP2008540514A (ja) 2005-05-10 2008-11-20 ダーミプソル リミテッド 過剰増殖表皮疾患の治療用組成物及び方法
AU2006253913B2 (en) 2005-06-01 2010-09-16 Mayne Pharma Llc Vitamin formulation
CA2610755A1 (en) * 2005-06-10 2006-12-14 Galderma S.A. Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
MXPA05009381A (es) * 2005-09-02 2007-03-01 Fernando Ahumada Ayala Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2007082533A1 (en) 2006-03-17 2007-07-26 Leo Pharma A/S Isomerisation of pharmaceutical intermediates
MX2009002337A (es) * 2006-08-29 2009-03-20 Teva Pharma Composiciones farmacologicamente estables que incluyen compuestos que contienen vitamina d y corticosteroides con compatibilidad con bajo ph.
FR2909284B1 (fr) 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090123390A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
EP2214652A2 (en) 2007-11-13 2010-08-11 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
US9254296B2 (en) * 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
ES2523119T3 (es) * 2009-12-22 2014-11-21 Leo Pharma A/S Nanocristales de monohidrato de calcipotriol
US20120322776A1 (en) * 2009-12-22 2012-12-20 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
MY167691A (en) 2010-06-11 2018-09-21 Leo Pharma As A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
CN103533962B (zh) 2011-03-14 2018-05-18 药品配送方案有限公司 一种眼用组合物
JP5897299B2 (ja) * 2011-10-14 2016-03-30 岩城製薬株式会社 ローション剤
CN104138352B (zh) * 2013-04-19 2018-02-27 江苏知原药业有限公司 卡泊三醇非水凝胶
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
LT3310389T (lt) * 2015-06-18 2020-11-10 Bausch Health Ireland Limited Vietinio vartojimo kompozicijos, apimančios kortikosteroidą ir retinoidą, skirtos psoriazės gydymui
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
KR102354028B1 (ko) 2020-05-13 2022-01-24 동국대학교 경주캠퍼스 산학협력단 건선 예방, 개선 또는 치료용 피부 외용제 조성물
CN114159567B (zh) * 2020-09-10 2023-03-31 南京海融医药科技股份有限公司 一种治疗皮肤病的混悬凝胶剂
CN115569199A (zh) * 2022-02-14 2023-01-06 南京海融医药科技股份有限公司 一种药物组合物及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
SE457055B (sv) * 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US5002938A (en) 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
ATE104554T1 (de) * 1990-01-10 1994-05-15 Hoffmann La Roche Topische praeparate.
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
US5763428A (en) * 1990-09-21 1998-06-09 Bone Care International, Inc. Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
JP2571493B2 (ja) * 1992-06-04 1997-01-16 株式会社資生堂 皮膚外用剤
DK0614456T3 (da) * 1992-08-28 1999-12-06 Bone Care Int Inc 1alfa,24(S)-dihydroxy-vitamin D2, dets fremstilling og anvendelse
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
DE4328217C2 (de) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutisches System zur Behandlung der Psoriasis
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
FR2740042B1 (fr) * 1995-10-23 1997-11-14 Oreal Support, et composition contenant ce support et un actif cosmetique ou dermatologique stabilise
JPH10158147A (ja) * 1996-11-29 1998-06-16 Kenji Nakamura 皮膚保護用の被膜組成物とそれを用いた製品
AU2387997A (en) * 1997-04-18 1998-11-13 Klinge Pharma Gmbh Stabilized medicaments containing cysteinyl derivatives
JPH11188054A (ja) * 1997-12-25 1999-07-13 Lion Corp 皮膚外用部材
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
FR2785284B1 (fr) * 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
PT2455083E (pt) * 1999-04-23 2013-10-09 Leo Pharma As Composição farmacêutica para aplicação dérmica compreendendo calcipotriol e betametasona para o tratamento da psoríase
MXPA03003511A (es) * 2000-10-27 2004-05-04 Leo Pharma As Composicion topica que contiene al menos una vitamina d o un analogo de vitamina de y al menos un corticosteroide.

Also Published As

Publication number Publication date
DK1331927T3 (da) 2008-05-05
PL360941A1 (en) 2004-09-20
KR100844285B1 (ko) 2008-07-09
EP1331927A1 (en) 2003-08-06
JP2008297310A (ja) 2008-12-11
IL154888A (en) 2013-12-31
JP5699169B2 (ja) 2015-04-08
HUP0302881A3 (en) 2012-03-28
WO2002034235A1 (en) 2002-05-02
AU9163701A (en) 2002-05-06
HUP0302881A2 (hu) 2003-12-29
CA2423930A1 (en) 2002-05-02
CA2423930C (en) 2009-11-24
MXPA03003511A (es) 2004-05-04
US6787529B2 (en) 2004-09-07
PL212660B1 (pl) 2012-11-30
BR0114927A (pt) 2003-12-23
CN1633280A (zh) 2005-06-29
DE60131881T2 (de) 2008-12-04
IL154888A0 (en) 2003-10-31
EP1331927B1 (en) 2007-12-12
CY1107294T1 (el) 2012-11-21
BR0114927B1 (pt) 2017-12-05
JP5721927B2 (ja) 2015-05-20
JP2013075924A (ja) 2013-04-25
AU2001291637B2 (en) 2006-04-06
CZ305984B6 (cs) 2016-06-08
RU2271810C2 (ru) 2006-03-20
ATE380542T1 (de) 2007-12-15
DE60131881D1 (de) 2008-01-24
CN100382803C (zh) 2008-04-23
JP4451061B2 (ja) 2010-04-14
BRPI0114927B8 (pt) 2021-05-25
HK1077208A1 (en) 2006-02-10
US20020111336A1 (en) 2002-08-15
ES2298264T3 (es) 2008-05-16
HU230005B1 (en) 2015-04-28
JP2004512297A (ja) 2004-04-22
KR20030048083A (ko) 2003-06-18

Similar Documents

Publication Publication Date Title
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
YU75701A (sh) Farmaceutski preparat
HK1060694A1 (en) Herbal compositions useful as chemopreventive and therapeutic agents.
SE0001899D0 (sv) New compounds
BR0210139A (pt) Composições farmacêuticas
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
WO2004021967A3 (en) Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
WO2003063824A3 (en) Pharmaceutical composition
WO2003105751A3 (en) NEW CURCUMIN DERIVATIVES
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
AU2003219046A1 (en) Cationic polymers and the use thereof in cosmetic formulations
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
HK1050203A1 (en) Novel fusidic acid derivatives.
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
WO2002070537A3 (en) Fusidic acid derivatives
MD1473F2 (en) Antiherpetic remedy
GB0128071D0 (en) Medicament
AU8028600A (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine
AU2003275360A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
ZA200207846B (en) Topical antioxidant vitamin composition for skin care.
ZA200201343B (en) Composition for topical administration comprising 5-methoxypsoralen.
ES2151869A1 (es) Composicion de un producto de aplicacion a la piel.
AU1022201A (en) Novel LTB4 antagonist, method for the production thereof and its use as a medicament